Development of a Fluorescence Polarization Assay for the Molecular Chaperone Hsp90
Authors:
- Sara FeltsSFSara Felts
- Laura LlaugerLLLaura Llauger
- Huazhong HeHHHuazhong He
- Henri HuezoHHHenri Huezo
- Neal RosenNRNeal Rosen
- Gabriela ChiosisGCGabriela Chiosis
Open Access
- 1 August 2004
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 9 (5) , 375-381
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine KinaseBioorganic & Medicinal Chemistry, 2002
- Hsp90 inhibitors as novel cancer chemotherapeutic agentsTrends in Molecular Medicine, 2002
- HSP90 as a new therapeutic target for cancer therapy: the story unfoldsExpert Opinion on Biological Therapy, 2002
- Coordinated ATP Hydrolysis by the Hsp90 DimerJournal of Biological Chemistry, 2001
- Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90Journal of Biological Chemistry, 2001
- Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)‐domain co‐chaperonesThe EMBO Journal, 1999
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999
- In Vivo Function of Hsp90 Is Dependent on ATP Binding and ATP HydrolysisJournal of Cell Biology, 1998
- ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivoThe EMBO Journal, 1998
- Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.Proceedings of the National Academy of Sciences of the United States of America, 1994